NY fund trustee to continue push for exec-pay clawbacks at Abbott
NY fund trustee to continue push for exec-pay clawbacks at Abbott Fierce Pharma
View ArticleAbbott should not be liable for additional Depakote damages, says Wells Fargo
Abbott should not be liable for additional Depakote damages, says Wells Fargo Yahoo/Fly on the Wall
View ArticleThese drugs are the cash cows of big pharma
These drugs are the cash cows of big pharma Quartz
View ArticleAbbVie Has Excellent Management Efficiency, But Is It A Buy?
AbbVie Has Excellent Management Efficiency, But Is It A Buy? Seeking Alpha
View ArticleAbbott says FDA approved heart valve medical device
Abbott says FDA approved heart valve medical device Reuters
View ArticleAIDS Group Sues Abbott And AbbVie Over 340B Drug Discounts
AIDS Group Sues Abbott And AbbVie Over 340B Drug Discounts Pharmalot
View ArticleAbbott Faces New Trial Over Gay Juror Exclusion in HIV drug pricing trial
Abbott Faces New Trial Over Gay Juror Exclusion in HIV drug pricing trial Bloomberg
View ArticlePharma shelled out $3.75B in fraud penalties in record-setting year, feds say
Pharma shelled out $3.75B in fraud penalties in record-setting year, feds say Fierce Pharma
View ArticleAbbott Labs Has Fallen and It Can't Get Up
Abbott Labs Has Fallen and It Can't Get Up TheStreet.com
View ArticleBig Pharma still betting on "messed up" Indian drugs market
Big Pharma still betting on "messed up" Indian drugs market Yahoo/Reuters
View ArticleAbbott First-Quarter Profit Beats Estimates on Diagnostic Tests
Abbott First-Quarter Profit Beats Estimates on Diagnostic Tests Bloomberg
View ArticleIs Abbott Laboratories Headed for a Breakup?
Is Abbott Laboratories Headed for a Breakup? Motley Fool
View ArticleShow me the money: Which drugs made the top 10 list on upfront deals?
Show me the money: Which drugs made the top 10 list on upfront deals? Fierce Biotech
View ArticleAbbott to buy Latin American drugmaker CFR in $2.9 billion deal
Abbott to buy Latin American drugmaker CFR in $2.9 billion deal Yahoo/Reuters
View Article[video]Can Abbott Laboratories Breathe Life into This Struggling Business?
[video]Can Abbott Laboratories Breathe Life into This Struggling Business? Motley Fool
View ArticleAbbott to buy Russian drug maker Veropharm, but says it’s not tax inversion deal
Abbott to buy Russian drug maker Veropharm, but says it’s not tax inversion deal Marketwatch
View ArticleAbbott CEO says interested in acquiring more medical devices
Abbott CEO says interested in acquiring more medical devices Yahoo/Reuters
View ArticleAbbott Labs shares climb 2.7% as profit, sales top estimates
Abbott Labs shares climb 2.7% as profit, sales top estimates Marketwatch
View ArticleWhy Abbott's Stake In Mylan Will Be Value-Creative
Why Abbott's Stake In Mylan Will Be Value-Creative Seeking Alpha
View Article